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ABSTRACT
Primary lymphoma in gastrointestinal tract is not very common. Ileocecal region is the commonest site for 
primary lymphoma and diffuse large B cell lymphoma (DLBCL) is the most prevalent subtype. The clinical 
presentation in this condition is pain in right lower quadrant region and this can very confusing since many 
diseases can also cause this problem like infection and inflammatory disease. In this paper, we report a case of 
primary lymphoma subtype DLBCL in ileocecal region that come to emergency department with ileus obstruction. 
Abdominal computerized tomography (CT) scan and colonoscopy revealed tumour in ileocecal region ascendens 
colon. Hemicolectomy was performed and the specimen was sent to pathology which revealed non-Hodgkin 
lymphoma with subtype DLBCL CD20 (+). The patient had undergone of Rituximab, Cyclophosphamide, 
Doxorubicine, Vincristin, and Prednison (RCHOP) chemotherapy regimen and had complete remission.
Keywords: lymphoma, primary, ileocecal, RCHOP chemotherapy.
ABSTRAK
Limfoma primer di saluran cerna jarang ditemukan. Regio ileosekal merupakan lokasi limfoma primer 
yang sering terjadi dan diffuse large B cell lymphoma (DLBCL) adalah subtipe limfoma non-Hodgkin yang 
paling sering terjadi pada regio ileosekal. Presentasi klinis DLBCL ileosekal tidak khas yaitu nyeri abdomen 
kuadran kanan bawah, yang bisa juga ditemukan pada penyakit-penyakit lainnya seperti infeksi dan penyakit-
penyakit inflamasi saluran cerna. Kami melaporkan sebuah kasus DLBCL ileosekal yang datang ke unit gawat 
darurat dengan keluhan ileus obstruksi. Computerized tomography (CT) scan abdomen dan kolonoskopi 
menunjukkan tumor di kolon asenden ileosekal. Pasien menjalani operasi hemikolektomi dan hasil patologi 
anatomi menunjukkan limfoma non hodgkin jenis DLBCL CD 20 (+). Selanjutnya pasien menjalani program 
kemoterapi Rituximab, Cyclophosphamide, Doxorubicine, Vincristin, and Prednison (RCHOP) dan respon 
pasca kemoterapi RCHOP adalah remisi komplit. 
Kata kunci: limfoma, primer, ileokal, terapi RCHOP
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INTRODUCTION
Gastrointestonal tract is the most common place 
for extranodal metastasis by lymphoma that account 
5-20% from all cases.1 But primary gastrointestinal 
lymphoma, precisely small intestine is very rare that 
accounts about less than 2% of all gastrointestinal 
malignancies. From the small intestine lymphoma 
accounts 20-30% of all small intestine neoplasm, 
which ileocecal is the most common site (60-65%).2 
From primary intestinal Lymphoma B-cell Lymphoma 
is more frequent than T-Cell, with DLBCL is the most 
common subtype.
DLBCL ileosekal may have presenting symptoms 
such as abdominal pain, weight loss, ileus obstruction, 
or intussuception.3,4,5 There are many diseases 
affecting ileocecal region such as malignant tumour, 
inflammatory disease, infectious disease, and 
miscellaneous condition.6
RCHOP chemotherapy is the first line treatment of 
DLBCL and consists of Rituximab combination with 
Cyclophosphamide, Doxorubicine, Vincristin, and 
Prednison. The response rate of treatment of DLBCL 
with RCHOP is good.4
CASE ILLUSTRATION
A 61 year old male with chief complaint pain 
in right illiac fossa come to emergency department 
of three months duration with a sudden increase in 
severity of pain.The pain started in epigastric then 
radiating to right illiac fossa. He had history of weight 
loss 20 kg in 3 months, decrease appetite, no night 
sweat. Physical examination revealed abdominal 
bloating and mass in right lower quadrant region. 
His laboratory examination revealed normochromic 
normocytic anemua, leucocytosis with high level 
serum lactic dehydrogenase(915 U/L). CT scan of 
the abdomen (Figure 1) revealed calcified mass in 
the colon region cecum with peripancreatic and left 
paraaortic lymphadenopathy, while colonoscopy 
(Figure 2) revealed tumour in colon ileocecal region. 
A right hemicolectomy was performed and the 
specimens of the tumour were sent to pathology. A 
histology diagnosis Non Hodgkin Lymphoma was 
made then immunohistochemistry result was positive 
for CD 20, CD 10, Ki-67 confirming the diagnosis of 
diffuse large B-cell lymphoma (DLBCL) with germinal 
center B-cell like subtype.
Figure 2. Colonoscopy result from the patient showing tumor 
in ileocecal region
Figure 1. CT-scan result of the patient showed calcified mass in the colon region cecum with 
peripancreatic and left paraaortic lymphadenopahty  
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The patient then undergone chemoterapy with 
R-CHOP regiment 8 cycles and now had complete 
remission. Figure 3 and 4 below showed the abdominal 
PET CT and CT scan in abdominal region after 
chemotherapy and 6 months following the last RCHOP 
chemotherapy.
Figure 3. Abdominal PET SCAN post chemotherapy showed 
no tumour
Figure 4. Abdominal CT-scan 6 months post chemotherapy 
showed no tumour
Table 1. Several condition that can cause right lower abdominal quadrant problem6
Malignant tumour Inflammatory disease Infectious disease Misscellaneous tumour
Adenocarcinoma
Carcinoid tumour
Lymphoma
Metastatic tumour
Appendicitis
Diverticulitis
Chron disease
Ulcerative colitis
Tuberculosis
Infectious terminal ilitis
Inflammatory reaction to an extrinsic 
infectious procces
Thyphilitis (Neutropenic Colitis)
Ischemic condition
Volvulus of cecum
Ileocecal enteric duplication cyst
Endometriosis
DISCUSSION
Lymphoma in small intestine usually have 
presenting symptoms such as abdominal pain, nausea, 
vomitting, weight loss, abdominal mass, obstructive 
symptoms, intussuception, perforation, and diarrhea 
with commonest pathological subtypes DLBCL.3,4,5
Ileocecal region is relative short segment in 
gastrointestinal tract that have various component 
that close one to another. Because of this structure 
the diagnosis of pain in right illiac fossa must be 
made considering many condition such as malignant 
tumour, inflammatory disease, infectious disease, 
and miscellaneous condition.6 Table 1 below shown 
many condition that must be considered before made 
diagnostic related to pain in right illiac fossa.
Serum lactic dehyrogenase (LDH) is usually 
elevated at the time of the diagnosis of aggresive 
NHL. The high activity of LDH at the time of 
diagnosis reflects increased tumor bulk.7 Based on 
histology examination, DLBCL usually composed of 
intermediate large cells, which shows B-cell lineage 
with expression of pan B-cell antigens (CD 19, CD 
20, CD 22, CD79A, and PAX5/BSAP) and is less 
commonly positive for germinal centre cell markers 
(CD 10 and BCL 6).8We performed Computed 
Tomography (CT) scan to delineate the location of the 
tumor and it is now recommended as the gold standard 
for staging DBCL patients because more sensitivity for 
nodal and extranodal site.9
Tumor resection is the main treatment for primary 
gastrointestinal lymphoma because it also provide 
data to see the histology, staging, and extension for 
prognosis.10 In study by Kim SJ et al in DLBCL 
patient that had surgery have better overall survival 
than patient who did not. 11 While the recommended 
chemotherapy for DLBCL in patient 60-80 years 
old is R-CHOP (Rituximab, Cyclophosmamide, 
Doxorubicin, Vincristine, Prednisone) 8 cycles given 
every 21 days.12 Complete response was achieved in 
76% patients with R-CHOP regiment compared to 
CHOP with 63%, and disease progression were lower 
in R-CHOP regiment (9%) than in CHOP (22%) in 
study by Coffier et al.13
Primary Lymphoma that involved ileocecal region 
usually has better survival rates than in small and large 
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intestine.14 In this case hemicolectomy was done as the 
primary treatment, and then chemotherapy RCHOP 
definitely administered to the patient.
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